Naltrexone HCl

Naltrexone HCl
Trade Name Trexan
Orphan Indication For blockade of the pharmacological effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals
USA Market Approval USA
USA Designation Date 1985-03-11 00:00:00
Sponsor DuPont Pharmaceuticals;E.I. Du Pont De Nemours & Co.;Wilmington, Delaware, 19898